# Concentra Group Holdings Parent, Inc.: financial statements, quarterly

CON · NYSE · CIK 2014596 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/con.md) · [Financials](/companies/con/financials.md) · [Filings](/companies/con/filings.md) · [Insiders](/companies/con/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/con/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [474](/filings/0001628280-24-045543.md) | [441 d](/filings/0002014596-26-000029.md) | [468](/filings/0002014596-25-000022.md) | [478](/filings/0002014596-25-000037.md) | [490](/filings/0002014596-25-000046.md) | [465 d](/filings/0002014596-26-000029.md) | [501](/filings/0002014596-26-000044.md) | [551](/filings/0002014596-26-000056.md) | [573](/filings/0002014596-25-000046.md) | [539 d](/filings/0002014596-26-000029.md) | [570](/filings/0002014596-26-000044.md) | [606](/filings/0002014596-26-000056.md) |
| Operating income | $m | [80.9](/filings/0001628280-24-045543.md) | [49.3 d](/filings/0002014596-26-000029.md) | [75.5](/filings/0002014596-25-000022.md) | [83.9](/filings/0002014596-25-000037.md) | [86.2](/filings/0002014596-25-000046.md) | [59.1 d](/filings/0002014596-26-000029.md) | [80.3](/filings/0002014596-26-000044.md) | [89.5](/filings/0002014596-26-000056.md) | [94.5](/filings/0002014596-25-000046.md) | [69.7 d](/filings/0002014596-26-000029.md) | [95.6](/filings/0002014596-26-000044.md) | [115](/filings/0002014596-26-000056.md) |
| Interest expense | $m | not reported | not reported | [0.1](/filings/0002014596-25-000022.md) | not reported | not reported | not reported | [25.5](/filings/0002014596-26-000044.md) | not reported | not reported | not reported | [26.0](/filings/0002014596-26-000044.md) | not reported |
| Income tax | $m | [15.2](/filings/0001628280-24-045543.md) | [9.9 d](/filings/0002014596-26-000029.md) | [15.1](/filings/0002014596-25-000022.md) | [18.1](/filings/0002014596-25-000037.md) | [16.4](/filings/0002014596-25-000046.md) | [9.8 d](/filings/0002014596-26-000029.md) | [13.3](/filings/0002014596-26-000044.md) | [15.2](/filings/0002014596-26-000056.md) | [16.0](/filings/0002014596-25-000046.md) | [6.6 d](/filings/0002014596-26-000029.md) | [17.3](/filings/0002014596-26-000044.md) | [22.0](/filings/0002014596-26-000056.md) |
| Net income | $m | [53.1](/filings/0001628280-24-045543.md) | [27.8 d](/filings/0002014596-26-000029.md) | [49.0](/filings/0002014596-25-000046.md) | [51.7](/filings/0002014596-25-000046.md) | [44.3](/filings/0002014596-25-000046.md) | [21.5 d](/filings/0002014596-26-000029.md) | [38.9](/filings/0002014596-26-000056.md) | [44.6](/filings/0002014596-26-000056.md) | [48.3](/filings/0002014596-25-000046.md) | [34.7 d](/filings/0002014596-26-000029.md) | [50.5](/filings/0002014596-26-000056.md) | [65.3](/filings/0002014596-26-000056.md) |
| Diluted EPS | $ per share | [0.51](/filings/0001628280-24-045543.md) | not reported | [0.47](/filings/0002014596-25-000022.md) | [0.50](/filings/0002014596-25-000037.md) | [0.37](/filings/0002014596-25-000046.md) | not reported | [0.30](/filings/0002014596-26-000044.md) | [0.35](/filings/0002014596-26-000056.md) | [0.38](/filings/0002014596-25-000046.md) | not reported | [0.39](/filings/0002014596-26-000044.md) | [0.51](/filings/0002014596-26-000056.md) |
| Basic EPS | $ per share | [0.51](/filings/0001628280-24-045543.md) | not reported | [0.47](/filings/0002014596-25-000022.md) | [0.50](/filings/0002014596-25-000037.md) | [0.37](/filings/0002014596-25-000046.md) | not reported | [0.30](/filings/0002014596-26-000044.md) | [0.35](/filings/0002014596-26-000056.md) | [0.38](/filings/0002014596-25-000046.md) | not reported | [0.39](/filings/0002014596-26-000044.md) | [0.51](/filings/0002014596-26-000056.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [31.4](/filings/0002014596-25-000011.md) | not reported | [50.7](/filings/0001628280-24-038538.md) | [137](/filings/0001628280-24-045543.md) | [183](/filings/0002014596-26-000029.md) | [52.1](/filings/0002014596-25-000022.md) | [73.9](/filings/0002014596-25-000037.md) | [49.9](/filings/0002014596-25-000046.md) | [79.9](/filings/0002014596-26-000056.md) | [61.7](/filings/0002014596-26-000044.md) | [158](/filings/0002014596-26-000056.md) |
| Current assets | $m | not reported | [294](/filings/0002014596-25-000011.md) | not reported | [320](/filings/0001628280-24-038538.md) | [410](/filings/0001628280-24-045543.md) | [437](/filings/0002014596-26-000029.md) | [352](/filings/0002014596-25-000022.md) | [395](/filings/0002014596-25-000037.md) | [375](/filings/0002014596-25-000046.md) | [383](/filings/0002014596-26-000056.md) | [404](/filings/0002014596-26-000044.md) | [506](/filings/0002014596-26-000056.md) |
| Total assets | $m | [2,297](/filings/0002014596-25-000011.md) | [2,334](/filings/0002014596-26-000029.md) | [2,366](/filings/0002014596-25-000022.md) | [2,363](/filings/0001628280-24-038538.md) | [2,481](/filings/0001628280-24-045543.md) | [2,521](/filings/0002014596-26-000029.md) | [2,729](/filings/0002014596-25-000022.md) | [2,842](/filings/0002014596-25-000037.md) | [2,844](/filings/0002014596-25-000046.md) | [2,858](/filings/0002014596-26-000056.md) | [2,890](/filings/0002014596-26-000044.md) | [3,010](/filings/0002014596-26-000056.md) |
| Current liabilities | $m | not reported | [275](/filings/0002014596-25-000011.md) | not reported | [265](/filings/0001628280-24-038538.md) | [270](/filings/0001628280-24-045543.md) | [307](/filings/0002014596-26-000029.md) | [320](/filings/0002014596-25-000022.md) | [335](/filings/0002014596-25-000037.md) | [313](/filings/0002014596-25-000046.md) | [337](/filings/0002014596-26-000056.md) | [321](/filings/0002014596-26-000044.md) | [368](/filings/0002014596-26-000056.md) |
| Total liabilities | $m | not reported | [1,156](/filings/0002014596-25-000011.md) | not reported | [1,093](/filings/0001628280-24-038538.md) | [2,180](/filings/0001628280-24-045543.md) | [2,222](/filings/0002014596-26-000029.md) | [2,398](/filings/0002014596-25-000022.md) | [2,474](/filings/0002014596-25-000037.md) | [2,434](/filings/0002014596-25-000046.md) | [2,438](/filings/0002014596-26-000056.md) | [2,436](/filings/0002014596-26-000044.md) | [2,504](/filings/0002014596-26-000056.md) |
| Shareholders' equity | $m | [979](/filings/0002014596-26-000029.md) | [1,161](/filings/0002014596-26-000029.md) | [1,201](/filings/0002014596-25-000046.md) | [1,247](/filings/0001628280-24-038538.md) | [278](/filings/0001628280-24-045543.md) | [276](/filings/0002014596-26-000029.md) | [307](/filings/0002014596-25-000022.md) | [343](/filings/0002014596-25-000037.md) | [385](/filings/0002014596-25-000046.md) | [393](/filings/0002014596-26-000056.md) | [425](/filings/0002014596-26-000044.md) | [477](/filings/0002014596-26-000056.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [58.6 d](/filings/0001628280-24-045543.md) | [76.2 d](/filings/0002014596-26-000029.md) | [44.6](/filings/0002014596-25-000022.md) | [70.4 d](/filings/0002014596-25-000037.md) | [65.9 d](/filings/0002014596-25-000046.md) | [93.7 d](/filings/0002014596-26-000029.md) | [11.7](/filings/0002014596-26-000044.md) | [88.4 d](/filings/0002014596-26-000056.md) | [60.6 d](/filings/0002014596-25-000046.md) | [119 d](/filings/0002014596-26-000029.md) | [21.0](/filings/0002014596-26-000044.md) | [135 d](/filings/0002014596-26-000056.md) |
| Capital expenditure | $m | [15.5 d](/filings/0001628280-24-045543.md) | [23.6 d](/filings/0002014596-26-000029.md) | [17.2](/filings/0002014596-25-000022.md) | [15.3 d](/filings/0002014596-25-000037.md) | [15.1 d](/filings/0002014596-25-000046.md) | [16.7 d](/filings/0002014596-26-000029.md) | [15.7](/filings/0002014596-26-000044.md) | [25.2 d](/filings/0002014596-26-000056.md) | [21.2 d](/filings/0002014596-25-000046.md) | [20.2 d](/filings/0002014596-26-000029.md) | [11.1](/filings/0002014596-26-000044.md) | [15.7 d](/filings/0002014596-26-000056.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0002014596-25-000046.md) | [8.0 d](/filings/0002014596-26-000029.md) | [0.0](/filings/0002014596-26-000044.md) | [16.0 d](/filings/0002014596-26-000056.md) | [8.0](/filings/0002014596-26-000029.md) | [8.0](/filings/0002014596-26-000029.md) | [8.0](/filings/0002014596-26-000056.md) | [8.0](/filings/0002014596-26-000056.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | period not labelled (2023-06-30) | period not labelled (2023-09-30) | period not labelled (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [104](/filings/0001628280-24-038538.md) | [104](/filings/0001628280-24-045543.md) | [104](/filings/0002014596-25-000022.md) | [104](/filings/0002014596-25-000037.md) | [121](/filings/0002014596-25-000046.md) | [128](/filings/0002014596-26-000044.md) | [128](/filings/0002014596-26-000056.md) | [128](/filings/0002014596-25-000046.md) | [128](/filings/0002014596-26-000044.md) | [128](/filings/0002014596-26-000056.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 127,517,736 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0002014596-26-000056.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.